Breaking News
February 16, 2019 - Men’s porn habits could fuel partners’ eating disorders, study suggests
February 16, 2019 - Rapid progression of age-related diseases may result from formation of vicious cycles
February 16, 2019 - Immune checkpoint molecule protects against future development of cancer
February 16, 2019 - New method produces hydrogels that have properties similar to cells’ environment
February 16, 2019 - $4.1 million funding for heart research on Valentine’s Day
February 16, 2019 - General anesthesia in early infancy unlikely to have lasting effects on developing brains
February 16, 2019 - New breakthroughs for muscular dystrophy research
February 16, 2019 - First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
February 16, 2019 - Vapers develop cancer-related gene deregulation as cigarette smokers
February 16, 2019 - Bringing Antimicrobial Susceptibility Testing (AST) to the Community
February 16, 2019 - Decolonization protocol after hospital discharge can prevent dangerous infections
February 16, 2019 - Therapeutic endoscopy has an expanding role in the treatment of IBD
February 16, 2019 - Intervention can increase exclusive breastfeeding rates
February 16, 2019 - New project explores how gaming technologies can help cancer patients communicate better
February 16, 2019 - Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
February 16, 2019 - Rerouting nerves during amputation reduces phantom limb pain before it starts
February 16, 2019 - A Hormone Produced When We Exercise Might Help Fight Alzheimer’s
February 16, 2019 - Millions of British people breathe toxic air travelling to GPs
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
February 15, 2019 - UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s
February 15, 2019 - New rules requiring female athletes to lower testosterone levels are based on flawed data
February 15, 2019 - Researchers comprehensively sequence the human immune system
February 15, 2019 - Researchers study animal venoms to identify new medicines for treating diseases
February 15, 2019 - Movement of wrist bones revealed by MRI and computer modeling
February 15, 2019 - Philips introduces new premium digital X-ray room to help shorten patient wait times
February 15, 2019 - Women fare worse than men following aortic heart surgery, study finds
February 15, 2019 - High-protein and low-calorie diet helps older adults lose weight safely, shows study
February 15, 2019 - Drug microdosing effects may not measure up to big expectations
February 15, 2019 - Discharged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
February 15, 2019 - A digitized lab environment to be showcased at smartLAB 2019
February 15, 2019 - Scientists uncover main mechanisms of fluconazole drug resistance
February 15, 2019 - New study seeks to understand how colibactin causes cancer
February 15, 2019 - Photoacoustic imaging accurately measures the temperature of deep tissues
February 15, 2019 - Large study finds no association between phthalate exposure and breast cancer risk
February 15, 2019 - New research explains presence of ‘natural’ magnetism in human cells
February 15, 2019 - Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients
February 15, 2019 - Excessive daytime sleepiness in OSA patients linked to greater risk for cardiovascular diseases
February 15, 2019 - Scientists shed light on damaging cell effects linked to aging
February 15, 2019 - Celiac disease may be caused by stomach bug in childhood
February 15, 2019 - NHS performance figures highlight the true scale of Emergency Department crisis
February 15, 2019 - High intensity exercise may improve health by increasing gut microbiota diversity
February 15, 2019 - Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
February 15, 2019 - Couples creating art or playing board games release ‘love hormone’
February 15, 2019 - Glimpsing The Future At Gargantuan Health Tech Showcase
February 15, 2019 - Common herbicide found to increase the risk of lymphoma
February 15, 2019 - Over-abundance of energy to cells could increase cancer risk
February 15, 2019 - Oxford Genetics appoints Jocelyne Bath as new Chief Operating Officer
February 15, 2019 - Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors
February 15, 2019 - Large-scale clinical trial begins to study liver transplantation between people with HIV
February 15, 2019 - Cannabis use among adolescents linked with increased risk of depression in adulthood
February 15, 2019 - Fractures, head injuries common in electric scooter accidents, UCLA study finds
February 15, 2019 - Prenatal maternal depression has important consequences for infant temperament, study shows
February 15, 2019 - Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer
February 15, 2019 - Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome
Lumitron HyperVIEW system set to redefine diagnosis and treatment of cancer

Lumitron HyperVIEW system set to redefine diagnosis and treatment of cancer

image_pdfDownload PDFimage_print

At an exclusive event held at University of California, Irvine (UCI) Applied Innovation Center, Lumitron Technologies, Inc. celebrated its arrival in the university’s prestigious Research Park and introduced the gathered luminaries to the HyperVIEW system. Lumitron’s laser-based, X-ray technology will boast imaging capabilities far beyond current medical standards to reach Superman® resolutions and have the unique ability to produce single color X-rays that enable cellular-level identification and treatment of disease.

The HyperVIEW platform utilizes a proprietary X-ray technology conceived and developed at the Lawrence Livermore National Laboratory (LLNL). Professor Chris Barty of UCI, former CTO of LLNL’s National Ignition Facility and Photon Science Directorate, home of the world’s largest laser system, has overseen the establishment of Lumitron’s commercial endeavor in Irvine, CA and is now shepherding the company’s development of the patents he helped create. Lumitron holds exclusive commercial development rights.

According to Prof. Barty, the HyperVIEW technology presents the potential to create the first true theranostics machine capable of both unprecedented imaging detail and cellular level treatment, simultaneously. The implications for medical applications in particular are astounding.

“As part of its mission, LLNL develops transformational technologies that can be transferred to industry for the public benefit,” said Richard Rankin, director, LLNL Innovation and Partnerships Office. “This represents a major step forward in achieving that objective.”

The HyperVIEW system, is the first major leap forward in imaging capabilities since X-rays were discovered in the late 1800s. Referring to the platform’s potential to selectively locate and treat disease without patient movement, world renowned uro-oncologist, Professor Phil Stricker, Chairman Department Urology St Vincent’s Sydney & Director of The Australian Prostate Cancer Research Center – NSW commented that the Lumitron’s platform would “…have the potential to change everything. With it, we have the potential to image and treat cancer precisely and non-invasively. It could eliminate surgery.”

Lumitron has now established its global R&D and manufacturing facility within the industrial research park of the University of California, Irvine, home of the world-renowned Beckman Laser Institute and Medical Clinic. Establishment of the company’s headquarters in Irvine will provide Lumitron, and its university research partners, the opportunity to work collaboratively going forward.

“We see this as a pivotal moment in imaging,” said Dr. Bruce Tromberg, Professor of Biomedical Engineering and Surgery, and Director of the Beckman Laser Institute and Medical Clinic, co-located on the UCI campus. “As this technology becomes a reality, our teams are excited to work alongside Professor Barty and Lumitron to explore the implementation possibilities. There is little doubt that this represents a new frontier for medicine.”

The collaborative nature of the UCI Applied Innovations initiative was a key factor in the location selection. The university’s commitment to entrepreneurial endeavors and nurturing new technologies has enabled Lumitron to locate its facility among leaders in technology and applied sciences.

“We are excited about the potential of this technology,” said Pramod P. Khargonekar, Vice Chancellor for Research, University of California, Irvine. “This is what is so exciting about the growth in UCI research: our ability to attract top tier innovators and very quickly commercialize technologies, going from breakthrough research to practical application in the marketplace.” Khargonekar went on to note that UCI students will also benefit from Lumitron’s establishment at UCI explaining that Professor Barty’s arrival includes development of an applied innovations lab on campus.

Lumitron is already looking beyond the medical applications of its technology. The HyperVIEW system holds many industrial implications. The powerful platform’s imaging and elemental-analysis capabilities are already being contemplated for use in a variety of industries that have long struggled with next-gen imaging needs such as homeland security and 3D manufacturing.

“This new, accessible science will commercially enable breakthrough applications beyond medicine and has applicability to non-destructive materials evaluation, 3D printing, mining, waste management and security,” said Mr. Maurie Stang, founder of Lumitron. Stang continued, “…Lumitron’s initial focus will be to market its HyperVIEW systems to leading international research institutes and university hospitals to support the development of new applications as well as harness the capability and innovation of many leading institutions in their respective fields throughout the world.”

The HyperVIEW platform leverages three complete generations of machine design, construction and test at the Lawrence Livermore National Laboratory and more than USD$220 million of R&D in advanced X-ray, laser and accelerator science undertaken by the U.S. Department of Energy.

Source:

https://www.lumitronxrays.com/news/lumitron-hyperview-will-tranform-diagnosis-treatment

Tagged with:

About author

Related Articles